Ravi Viswanathan, 10% Owner at AVEO PHARMACEUTICALS INC (AVEO), bought 192,425 shares at $2.10 ($404K) on 2018-06-28, disclosed to the SEC on 2018-06-28.
Open-market purchase of $404k AVEO by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.15 | 5,295 | $11K | 2.8% |
| 2 | $2.10 | 187,130 | $393K | 97.2% |
| Total | $2.10 avg | 192,425 | $404K | 100% |
| Filing → |
| AVEO | BUY | 2018-07-20 | $491K | — | Filing → |
| AVEO | BUY | 2018-05-30 | $591 | — | Filing → |
| AVEO | BUY | 2018-05-21 | $897K | — | Filing → |